
Overview
John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors.
Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.
His clinical research consists of co-authoring 15 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as a Distinguished provider by MediFind in the treatment of Gastric Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.
Monongalia County General Hospital Company
Michael Craig is a Hematologist Oncology specialist and a Hematologist in Morgantown, West Virginia. Dr. Craig is rated as a Distinguished provider by MediFind in the treatment of Gastric Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Craig is currently accepting new patients.
St. Clair Hospital Cancer Center, Affiliated With UPMC Hillman Cancer Center
Vincent Edgar Reyes, Jr., MD, is the chief medical officer of the UPMC Hillman Cancer Center Medical Oncology Network and assistant clinical professor of medicine at the University of Pittsburgh School of Medicine. Dr. Reyes is rated as a Distinguished provider by MediFind in the treatment of Gastric Lymphoma. His top areas of expertise are Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), Colorectal Cancer, and Paget Disease of the Breast.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Rhee isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Rhee isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Rhee isDistinguished. Learn about Familial Pancreatic Cancer.
- Lung CancerDr. Rhee isDistinguished. Learn about Lung Cancer.
- MesenchymomaDr. Rhee isDistinguished. Learn about Mesenchymoma.
- Pancreatic CancerDr. Rhee isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Rhee isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Appendix CancerDr. Rhee isAdvanced. Learn about Appendix Cancer.
- Bone TumorDr. Rhee isAdvanced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- EGFR Positive Lung CancerDr. Rhee isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Rhee isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Immune ThrombocytopeniaDr. Rhee isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Rhee isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Rhee isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Rhee isExperienced. Learn about Ampullary Cancer.


